
EvE Bio is a Focused Research Organization (FRO) with a five-year mission to map the pharmome, identifying unintended targets ('off-targets') of small-molecule drugs. They aim to provide comprehensive safety pharmacology profiling, enable drug repurposing, generate ground-truth data for AI-driven drug development, support polypharmacology research, offer chemical toxicology profiling, and create automation-friendly bioassays. Their approach involves adapting high-throughput screening technologies to test FDA-approved drugs against gene products, developing bespoke assays, and releasing all data and insights into the public domain.

EvE Bio is a Focused Research Organization (FRO) with a five-year mission to map the pharmome, identifying unintended targets ('off-targets') of small-molecule drugs. They aim to provide comprehensive safety pharmacology profiling, enable drug repurposing, generate ground-truth data for AI-driven drug development, support polypharmacology research, offer chemical toxicology profiling, and create automation-friendly bioassays. Their approach involves adapting high-throughput screening technologies to test FDA-approved drugs against gene products, developing bespoke assays, and releasing all data and insights into the public domain.